ANTIBODIES THAT BIND TO THE NIDOGEN-BINDING DOMAIN OF LAMININ, THEIR PRODUCTION AND USE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20010007020A1
SERIAL NO

09341643

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to monoclonal and polyclonal antibodies, and their parts, which bind specifically to the nidogen-binding domain of laminin, to processes for their preparation and to their use as pharmaceuticals, as diagnostic agents for detecting laminin isoforms and as model substances for developing and evaluating substances which affect the nidogen/laminin interaction. The antibodies according to the invention, or their parts, bind preferentially to the laminin .gamma.1 III 4 domain, in particular in the highly conserved region of the a and c loops, and are able to inhibit the association of laminin and nidogen.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HOECHST AKTIENGESELLSCHAFTFRANKFURT/MAIN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
GERL, MARTIN NIEDERNHAUSEN, DE 7 78

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation